Publications by authors named "Nicholas A Moore"

Claim this Profile
C
CSTI-300 (SMP-100); a Novel 5-HT Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome.
Alexander Roberts, Gillian Grafton, Andrew D Powell, Kristian Brock, Chunlin Chen, Nicholas A Moore

J Pharmacol Exp Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anterior vestibule salvaging technique to limit silicone orbital implant extrusion following evisceration.
Nicholas A Moore, Roxana Fu, Jeremy Clark, Mark Prendes, William R Nunery

Orbit· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of drought and fire on resprouting capacity of 52 temperate Australian perennial native grasses.
Nicholas A Moore, James S Camac, John W Morgan

New Phytol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review.
Peter Bracha, Nicholas A Moore, Thomas A Ciulla, Darrell WuDunn, Louis B Cantor

Surv Ophthalmol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm.
Jeremy Clark, John Randolph, Jason A Sokol, Nicholas A Moore, Hui Bae H Lee

Digit J Ophthalmol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Neonate With Acute Dacryocystitis.
Nicholas A Moore, Rao V Chundury

JAMA Ophthalmol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy for inherited retinal and optic nerve degenerations.
Nicholas A Moore, Nuria Morral, Thomas A Ciulla, Peter Bracha

Expert Opin Biol Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neomycin, polymyxin B, and dexamethasone allergic reactions following periocular surgery.
Nicholas A Moore, Craig N Czyz, Tracy D Carter, Jill A Foster, Kenneth V Cahill

J Ophthalmic Inflamm Infect· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy for age-related macular degeneration.
Nicholas A Moore, Peter Bracha, Rehan M Hussain, Nuria Morral, Thomas A Ciulla

Expert Opin Biol Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced pluripotent stem cell-based therapy for age-related macular degeneration.
Peter Bracha, Nicholas A Moore, Thomas A Ciulla

Expert Opin Biol Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline retrobulbar blood flow is associated with both functional and structural glaucomatous progression after 4 years.
Nicholas A Moore, Alon Harris, Scott Wentz, Alice Chandra Verticchio Vercellin, Priyanka Parekh

Br J Ophthalmol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.
Christopher L Cioffi, Shuang Liu, Mark A Wolf, Peter R Guzzo, Kashinath Sadalapure, Nicholas A Moore

J Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in Retrobulbar and Retinal Capillary Blood Flow Strongly Correlate With Changes in Optic Nerve Head and Retinal Morphology Over 4 Years in Open-angle Glaucoma Patients of African Descent Compared With Patients of European Descent.
Brent Siesky, Alon Harris, Joseph Carr, Alice Verticchio Vercellin, Rehan M Hussain, Nicholas A Moore

J Glaucoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age as a factor in do not attempt cardiopulmonary resuscitation decisions: a multicentre blinded simulation-based study.
Nicholas A Moore, Natasha Wiggins, Joe Adams

Palliat Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From preclinical to clinical development: the example of a novel treatment for obesity.
Nicholas A Moore, Bruce J Sargent, Peter R Guzzo, Matthew D Surman

Neurobiol Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial agonism of 5-HT3 receptors: a novel approach to the symptomatic treatment of IBS-D.
Nicholas A Moore, Bruce J Sargent, David D Manning, Peter R Guzzo

ACS Chem Neurosci· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New central targets for the treatment of obesity.
Bruce J Sargent, Nicholas A Moore

Br J Clin Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats.
Abegale W Hartfield, Nicholas A Moore, Peter G Clifton

Neuropsychopharmacology· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Kurt Rasmussen, Mark J Benvenga, Frank P Bymaster, David O Calligaro, Ilene R Cohen, Nicholas A Moore

J Pharmacol Exp Ther· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonergic and histaminergic mechanisms involved in intralipid drinking?
Abegale W Hartfield, Nicholas A Moore, Peter G Clifton

Pharmacol Biochem Behav· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models of depression: are there any?
Michael F O'Neil, Nicholas A Moore

Hum Psychopharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.
Abegale W Hartfield, Nicholas A Moore, Peter G Clifton

Psychopharmacology (Berl)· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioural pharmacology of polygalasaponins indicates potential antipsychotic efficacy.
In-Won Chung, Nicholas A Moore, Won-Keun Oh, Michael F O'Neill, Jong-Seog Ahn

Pharmacol Biochem Behav· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis